Clinical trial Recruiting at 1 site Observational Ages 18 to 40

Pain, function, and social appearance in adults after shoulder tendon transfer for obstetric brachial plexus palsy

Official title: Evaluation of Pain, Upper Extremity Function, and Social Appearance Anxiety in Adults With Obstetric Brachial Plexus Palsy Who Underwent Shoulder Tendon Transfer Surgery

Run by Biruni University · NCT07655271 · Data updated 2026-11-12

This study tests how adults who had a shoulder tendon transfer in childhood fare in pain, arm movement, strength, daily function, and social appearance compared with healthy peers.

More Brachial Plexus Birth Palsy trials

Quick facts

Study typeObservational
Ages18 Years to 40 Years
SexAll
Enrollment80 (estimated)
SponsorBiruni University
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedJune 17, 2026
Trial IDNCT07655271 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–40 with unilateral obstetric brachial plexus palsy who had a Modified Hoffer shoulder tendon transfer at least 5 years ago.

Probably not a fit

Adults without these specific surgical history or those not willing to participate may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cross-sectional observational study conducted at Biruni University to describe long-term outcomes in adults who had a Modified Hoffer shoulder tendon transfer for obstetric brachial plexus palsy during childhood. Participants and healthy controls will undergo a single assessment session measuring pain (numeric rating scale), range of motion, muscle strength, functional status, social appearance anxiety, and role performance. The study aims to characterize the clinical profile of these adults and compare results with age-matched controls to understand long-term postoperative outcomes. Ethical approval has been obtained and informed consent will be collected from all participants. The research is designed as a master's thesis and follows Helsinki Declaration principles.

Why it matters

Potential benefit: Findings may improve understanding of long-term outcomes after Modified Hoffer tendon transfer and inform patient expectations and follow-up care.

How similar studies have gone: Other studies have described long-term outcomes after similar shoulder procedures, though this exact cross-sectional approach in this population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion and Exclusion Criteria

Inclusion Criteria for Individuals With Brachial Plexus Birth Palsy:

* Being between 18 and 40 years of age.
* Having a diagnosis of unilateral brachial plexus birth palsy.
* Having undergone shoulder tendon transfer surgery using the Modified Hoffer Technique.
* Having at least 5 years elapsed since the last surgery.
* Having a cognitive and communication level sufficient to comply with the assessment process.
* Agreeing to participate voluntarily in the study and signing the informed consent form.

Inclusion Criteria for Healthy Individuals:

* Being between 18 and 40 years of age.
* Having no history of upper extremity-related surgery within the last 5 years.
* Having a cognitive and communication level sufficient to comply with the assessment process.
* Agreeing to participate voluntarily in the study and signing the informed consent form.

Exclusion Criteria for All Participants:

* Having a neurological disease.
* Having another orthopedic problem or a history of trauma in the affected upper extremity.
* Having a history of systemic disease requiring an acute attack or hospitalization within the last 3 months.
* Pregnancy or being less than 6 months postpartum.

Where it's running

  • Biruni University
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.